Wolfgang Leitner is a programofficer ,chief, innate immunity AND vaccine adjuvants section in NIAID,NIH,USA.His recent publications are on following: 1. Gene gun immunization to combat malaria. 2. Improving DNA vaccines against malaria: could immunization by gene gun be the answer? 3. Is arthropod saliva the achilles' heel of vector-borne diseases? He has total of 74 publications.
Professor Bernhagen studied Biochemistry and Immunology at the University of Tübingen, Germany, and at Queen Mary College, London, UK. He performed a sandwich PhD thesis at the University of Tübingen and at the Picower Institute for Medical Research, Manhasset, NY, USA, and was trained as a postdoc at the Picower. Professor Bernhagen currently is a Full Professor of Biochemistry and Molecular Cell Biology at RWTH Aachen University, Germany, and is the Chair and Director of the homonymous institute. His main research interest has been on cytokines, chemokines and their role in inflammation, with a focus on MIF and the biochemical and structural features and mechanisms of such inflammatory mediators. He also studies the COP9 signalosome. Studied disease models encompass rodent model of atherosclerosis, sepsis, liver and kidney disease as well as colitis and colorectal cancer. Professor Bernhagen has authored more than 120 peer-reviewed papers in these areas, several of them published in leading journals such as Nature, Nature Medicine, or PNAS. He has serves on the editorial board of several journals and serves on several review committees for extramural funding and various fellowship organizations.
Cytokines, chemokines and their role in inflammation, with a focus on MIF and the biochemical and structural features and mechanisms of such inflammatory mediators
Ivo Gut took on the direction of CNAG in January 2010. He leads the Applied Genomics group and is the Team Leader of the Biomedical Genomics team. He qualified in Chemistry at the University of Basel in 1985 and obtained a PhD in Physical Chemistry from the same university in 1990. Then he joined the research group of Prof. Irene Kochevar at Harvard Medical School as a research fellow. Between 1993 and 1996 he was research fellow with Dr. Stephan Beck at the Imperial Cancer Research Fund in London. Later, at the Max-Planck-Institute for Molecular Genetics he led a group in the Department for Vertebrate Genomics of Prof. Hans Lehrach. In the 11 years before joining the CNAG he worked at the Centre National de Génotypage of the Commissariat à l'Energie Atomique in Evry, France, first as Head of Technology Development and later as Associate Director under Prof. Mark Lathrop. His research interests are high-throughput nucleic acid analysis, sequencing, SNP genotyping, genomics, genetics, nucleic acid and protein analysis methods (molecular biological techniques and chemical modification), implementation of methods, automation and analysis. He is the author of over 160 research papers, inventor of 24 patents and patent applications, founder of 4 biotech companies (Genom Analytik GmbH, Biopsytec GmbH and Epigenomics AG, Integragen SA). He is the coordinator of the 12M€ EU FP7-funded Integrated Project READNA on DNA sequencing technology development.